How a top 20 biopharma company unified and streamlined launch practices to prepare for the global commercialization of a multibillion-dollar oncology portfolio.
Life science product launches are complicated and expensive. When two top 20 biopharma companies sought to streamline the launch readiness processes for 200+ global oncology launches in partnership, they jointly evaluated several platforms.
They selected Unipr for its comprehensive toolset, deep industry expertise, and simple yet elegant user experience.
Poised to generate $5 Bn in global revenues, their new oncology drug is yet another multi-indication global brand launched on tools built by Unipr — by the same team that has been collaborating since 2003 and previously created tools for launching Humira globally, which exceeded $20 Bn in annual revenues at its peak.
The video case study below offers valuable lessons for biopharma companies navigating complex global launches.
During a life science industry panel, a senior digital transformation leader from one of these top 20 biopharma shared how they unified and streamlined their launch practices to prepare for the global commercialization of a multibillion-dollar oncology portfolio.
Facing the challenge of managing multiple launches simultaneously and synchronizing the efforts of different cross-functional teams working in isolation with diverse processes, the organization implemented Unipr to harmonize its approach.
Here are the key takeaways from the discussion:
Before, different brand teams operated in silos, leading to fragmented launch strategies. With Unipr, the organization created a unified launch readiness process to ensure alignment across global, regional, and local teams.
Monthly status updates were once cumbersome and perceived as demoralizing. Now, they configured Unipr to streamline their progress updates process, significantly reducing manual effort and allowing teams to focus on strategic discussions rather than tedious administrative work.
Unipr's Gantt chart visuals and Critical Path analysis enabled multiple launch teams to adapt quickly to changing circumstances, with Scenario Plans in place to minimize last-minute scrambles.
Watch the video to discover how the top biopharma companies are simplifying launch processes to meet tight timelines and improve team alignment—ultimately making every launch better than the last.
